Penzel T, Sogorski S, Zelmer J, Fietze I, Vogtmann T, Baumann G, Schöbel C
CharitéCentrum für Herz-, Kreislauf- und Gefäßmedizin (CC11), Charité Campus Mitte, Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
Herzschrittmacherther Elektrophysiol. 2012 Mar;23(1):14-21. doi: 10.1007/s00399-011-0163-9.
Sleep-disordered breathing is one of the most common sleep disorders. Especially obstructive sleep apnea (OSA) is an independent cardiovascular risk factor. Clinical studies have proven a significant association between OSA and atrial fibrillation, the most common cardiac arrhythmia. Currently, there is no proven evidence for causality. Untreated OSA seems to be a risk factor for failure of rhythm control strategy in atrial fibrillation. The recurrence rate after cardioversion is higher in case of additional untreated OSA. Continuous positive airway pressure (CPAP) therapy in OSA patients could reduce relapse rate. However, there is a lack of randomized controlled clinical trials with defined end points on this topic. A specific sleep medicine interview as well as sleep studies with portable monitoring and cardiorespiratory polysomnography are recommended when sleep-disordered breathing is suspected. Procedures for the management of patients with atrial fibrillation are given.
睡眠呼吸障碍是最常见的睡眠障碍之一。尤其是阻塞性睡眠呼吸暂停（OSA）是一个独立的心血管危险因素。临床研究已证实OSA与心房颤动（最常见的心律失常）之间存在显著关联。目前，尚无确凿的因果关系证据。未经治疗的OSA似乎是心房颤动节律控制策略失败的一个危险因素。在存在未经治疗的OSA的情况下，心脏复律后的复发率更高。OSA患者的持续气道正压通气（CPAP）治疗可降低复发率。然而，在这个主题上缺乏有明确终点的随机对照临床试验。当怀疑有睡眠呼吸障碍时，建议进行特定的睡眠医学访谈以及采用便携式监测和心肺多导睡眠图的睡眠研究。文中给出了心房颤动患者的管理程序。
